NIH Grants & Funding /
Participating Organization: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
| FOA Number | Co-Funders | Title | Clinical Trial | Activity Code | Application Due Date |
|---|---|---|---|---|---|
| RFA-DK-21-004 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes | Optional | R01 | Closed22 June 2021 and 9 March 2022 |
| RFA-NS-22-034 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Center for Advancing Translational Sciences (NCATS), National Center for Complementary and Integrative Health (NCCIH), National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA), National Institute on Alcohol Abuse and Alcoholism (NIAAA) | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment | Not allowed | R01 | ClosedMarch 02, 2022 to October 02, 2024 |